The peptide derivatives were prepared by solid phase peptide synthesis (SPPS) using 2-Chlorotrityl Chloride Resin, and the corresponding N-Fmoc protected amino acids with side chains properly protected by a tertbutyl group (tBu) or 2,2,5,7,8-pentamethyl-chroman-6-sulfonyl (Pmc). 20% piperidine DMF solution was used during deprotection of the Fmoc group. O-Benzotriazol-1-yl-N,N,N′,N′-tetramethyluronium hexafluorophosphate (HBTU) was used as the coupling reagent. Finally, peptide derivative was cleaved using 95% of trifluoroacetic acid with 2.5% of PhSCH3 and 2.5% of H2O for 30 min. The crude products were purified by high performance liquid chromatography (HPLC) then frozen dried to obtain pure products.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.